FDA Requests More Info on PharmaTher’s Ketamine Application ...Middle East

Medscape - News
In a complete response letter, the FDA cited minor deficiencies related to drug substance, product, manufacturing and microbiology in the company’s abbreviated new drug application for ketamine. Medscape Medical News

Hence then, the article about fda requests more info on pharmather s ketamine application was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Requests More Info on PharmaTher’s Ketamine Application )

Apple Storegoogle play

Last updated :

Also on site :